>_ QFI Terminal
Terminal › Stocks › WST

West Pharmaceutical Services, Inc. (WST) Stock

Healthcare · Medical - Instruments & Supplies · US
$412.86 +0.08%
Last updated Nov 12, 2026 09:20 UTC

WST Key Statistics

Market Cap$28.76B
P/E (TTM)46.35
P/S (TTM)8.47
P/B (TTM)9.79
Revenue (TTM)$3.40B
EPS (TTM)$8.91
Dividend Yield—
ROE (TTM)21.08%
Net Margin18.81%
Gross Margin37.59%
52W High$438.27
52W Low$223.83
Analyst ViewBuy
Price Target$427.43
Employees10,800
Volume326,736

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

CEO: Michel Lagarde. Company website

WST — Frequently Asked Questions

What is the WST stock price today?

West Pharmaceutical Services, Inc. (WST) trades at $412.86, up 0.08% on the day, as of Nov 12, 2026 09:20 UTC.

What is West Pharmaceutical Services, Inc.'s market cap?

West Pharmaceutical Services, Inc. has a market capitalisation of $28.76B, calculated from the live WST share price and shares outstanding.

What is the P/E ratio of WST?

WST trades at a trailing P/E of 46.35, from earnings per share of $8.91 over the last twelve months.

How much revenue does West Pharmaceutical Services, Inc. make?

West Pharmaceutical Services, Inc. generated revenue of $3.40B over the trailing twelve months, which puts the stock at 8.47 times sales.

What is the 52-week range for WST?

WST has traded between $223.83 and $438.27 over the past 52 weeks, and the last price is 5.8% below that high.

Is West Pharmaceutical Services, Inc. profitable?

Yes. West Pharmaceutical Services, Inc. keeps 18.81% of revenue as net income over the trailing twelve months.

What is the analyst price target for WST?

Wall Street analysts rate WST Buy, with an average price target of $427.43, 3.5% above the current price.

What sector is West Pharmaceutical Services, Inc. in?

West Pharmaceutical Services, Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.

Who is the CEO of West Pharmaceutical Services, Inc.?

Michel Lagarde is the chief executive of West Pharmaceutical Services, Inc., which employs 10,800 people.

Where can I track WST in real time?

QFI Terminal shows WST with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See WST live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open WST in Terminal See plans

Medical - Instruments & Supplies stocks

MDLN Medline Inc. BDX Becton, Dickinson and Company BAX Baxter International Inc. ISRG Intuitive Surgical, Inc. SOLV Solventum Corporation AVTR Avantor, Inc. RMD ResMed Inc. COO The Cooper Companies, Inc. HOLX Hologic, Inc. ATR AptarGroup, Inc. XRAY DENTSPLY SIRONA Inc. NVST Envista Holdings Corp TFX Teleflex Incorporated ICUI ICU Medical, Inc. MMSI Merit Medical Systems, Inc. RGEN Repligen Corporation MLSS Milestone Scientific Inc. GCTK GlucoTrack, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc. AZN AstraZeneca PLC NVS Novartis AG SNY Sanofi BMY Bristol-Myers Squibb Company ABT Abbott Laboratories TMO Thermo Fisher Scientific Inc.

ETFs holding WST

NOBL ProShares - S&P 500 Dividend Aristocrats ETF 1.40% XLV State Street Health Care Select Sector SPDR ETF 0.43% RSP Invesco S&P 500 Equal Weight ETF 0.23% MTUM iShares MSCI USA Momentum Factor ETF 0.20% VIG Vanguard Dividend Appreciation ETF 0.12% SDY State Street SPDR S&P Dividend ETF 0.11% VUG Vanguard Morningstar Growth ETF 0.10% QUAL iShares MSCI USA Quality Factor ETF 0.09% SCHG Schwab U.S. Large-Cap Growth ETF 0.08% IWD iShares Russell 1000 Value ETF 0.07% SPY State Street SPDR S&P 500 ETF 0.04% IVV iShares Core S&P 500 ETF 0.04% SCHX Schwab U.S. Large-Cap ETF 0.04% IWB iShares Russell 1000 ETF 0.04% FB ProShares S&P 500 Dynamic Buffer ETF 0.04% VOO Vanguard S&P 500 ETF 0.04% SCHB Schwab U.S. Broad Market ETF 0.04% FNDX Schwab Fundamental U.S. Large Company ETF 0.04% VTI Vanguard Morningstar Total Stock Market ETF 0.04% ACWI iShares MSCI ACWI ETF 0.03% UPRO ProShares - UltraPro S&P500 0.02% VT Vanguard Total World Stock ETF 0.02% DGRO iShares Core Dividend Growth ETF 0.02% SPXL Direxion Daily S&P 500 Bull 3X Shares 0.01%

Largest institutional holders of WST

BlackRock, Inc. BLK 6,651,784 shares
FMR LLC 5,988,538 shares
VANGUARD CAPITAL MANAGEMENT LLC 4,613,134 shares
VANGUARD PORTFOLIO MANAGEMENT LLC 4,015,766 shares
STATE STREET CORP STT 3,348,698 shares
Artisan Partners Limited Partnership 2,411,792 shares
GENERATION INVESTMENT MANAGEMENT LLP 2,028,322 shares
GEODE CAPITAL MANAGEMENT, LLC 1,936,541 shares
T. Rowe Price Investment Management, Inc. 1,805,019 shares
Bank of New York Mellon Corp 1,738,854 shares

WST insiders on other boards

MOH Molina Healthcare, Inc. Lockhart Stephen H ECL Ecolab Inc. Green Eric Mark BSY Bentley Systems, Incorporated Haugen Janet Brutschea XYL Xylem Inc. Friel Robert F IEX IDEX Corporation Buthman Mark A VRTX Vertex Pharmaceuticals Incorporated Lagarde Michel REPL Replimune Group, Inc. Pucci Paolo TMO Thermo Fisher Scientific Inc. Lagarde Michel FSLR First Solar, Inc. Joseph Molly A Agilent Technologies, Inc. McMahon Robert W.